GANO KYLE (Chief Business Development Off) received a stock award from NEUROCRINE BIOSCIENCES INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/15/2026ACC: 0001567160-26-000009
Officer· Chief Business Development Off
Since Aug 2018
+3.74K
Net shares
Net buyer
$684.2K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
8.12K acquired · 4.38K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+6.28K
Price / share
—
Trade value
—
% of position
4.2%
9/11/2026
150.99K→157.27K
Common Stock
Direct
Shares
−3.39K
Price / share
$156.22
Trade value
$528.96K
% of position
2.2%
9/11/2026
157.27K→153.88K
Common Stock
Direct
Shares
+1.84K
Price / share
—
Trade value
—
% of position
1.2%
9/11/2026
153.88K→155.72K
Common Stock
Direct
Shares
−994.00
Price / share
$156.22
Trade value
$155.28K
% of position
0.6%
9/11/2026
155.72K→154.73K
Total
Net shares
+3.74K
Net value
-$684.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | A · Award | +6.28K | — | — | 4.2% | 150.99K | 157.27K |
| Common Stock Direct | 9/11/2026 | F · Tax Withholding | −3.39K | $156.22 | $528.96K | 2.2% | 157.27K | 153.88K |
| Common Stock Direct | 9/11/2026 | A · Award | +1.84K | — | — | 1.2% | 153.88K | 155.72K |
| Common Stock Direct | 9/11/2026 | F · Tax Withholding | −994.00 | $156.22 | $155.28K | 0.6% | 155.72K | 154.73K |
| Total | +3.74K | -$684.24K | ||||||
Derivative Transactions0
No derivative transactions reported